Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies.
Gürgen D, Becker M, Dahlmann M, Flechsig S, Schaeffeler E, Büttner FA, Schmees C, Bohnert R, Bedke J, Schwab M, Wendler JJ, Schostak M, Jandrig B, Walther W, Hoffmann J. Gürgen D, et al. Among authors: schostak m. Front Oncol. 2022 Jun 21;12:889789. doi: 10.3389/fonc.2022.889789. eCollection 2022. Front Oncol. 2022. PMID: 35800063 Free PMC article.
Letter to the Editor Concerning "Irreversible Electroporation (IRE) Fails to Demonstrate Efficacy in a Prospective Multicenter Phase II Trial on Lung Malignancies: The ALICE Trial" by Ricke et al. 2015 (doi:10.1007/s00270-014-1049-0).
Wendler JJ, Porsch M, Fischbach F, Pech M, Schostak M, Liehr UB. Wendler JJ, et al. Among authors: schostak m. Cardiovasc Intervent Radiol. 2015 Aug;38(4):1064-5. doi: 10.1007/s00270-015-1096-1. Epub 2015 Apr 23. Cardiovasc Intervent Radiol. 2015. PMID: 25902855 No abstract available.
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
Wendler JJ, Porsch M, Nitschke S, Köllermann J, Siedentopf S, Pech M, Fischbach F, Ricke J, Schostak M, Liehr UB. Wendler JJ, et al. Among authors: schostak m. Contemp Clin Trials. 2015 Jul;43:10-9. doi: 10.1016/j.cct.2015.05.002. Epub 2015 May 9. Contemp Clin Trials. 2015. PMID: 25962890 Clinical Trial.
New aspects in shear-wave elastography of prostate cancer.
Porsch M, Wendler JJ, Liehr UB, Lux A, Schostak M, Pech M. Porsch M, et al. Among authors: schostak m. J Ultrason. 2015 Mar;15(60):5-14. doi: 10.15557/JoU.2015.0001. Epub 2015 Mar 30. J Ultrason. 2015. PMID: 26675385 Free PMC article.
Irreversible Electroporation of Prostate Cancer: Patient-Specific Pretreatment Simulation by Electric Field Measurement in a 3D Bioprinted Textured Prostate Cancer Model to Achieve Optimal Electroporation Parameters for Image-Guided Focal Ablation.
Wendler JJ, Klink F, Seifert S, Fischbach F, Jandrig B, Porsch M, Pech M, Baumunk D, Ricke J, Schostak M, Liehr UB. Wendler JJ, et al. Among authors: schostak m. Cardiovasc Intervent Radiol. 2016 Nov;39(11):1668-1671. doi: 10.1007/s00270-016-1390-6. Epub 2016 Jun 2. Cardiovasc Intervent Radiol. 2016. PMID: 27256102 No abstract available.
Systemic therapy in metastatic renal cell carcinoma.
Bedke J, Gauler T, Grünwald V, Hegele A, Herrmann E, Hinz S, Janssen J, Schmitz S, Schostak M, Tesch H, Zastrow S, Miller K. Bedke J, et al. Among authors: schostak m. World J Urol. 2017 Feb;35(2):179-188. doi: 10.1007/s00345-016-1868-5. Epub 2016 Jun 9. World J Urol. 2017. PMID: 27277600 Free PMC article. Review.
227 results